CompuGroup Medical SE & Co. KGaA (ETR:COP - Get Free Report)'s share price traded up 6.6% on Tuesday . The company traded as high as €15.04 ($15.83) and last traded at €14.98 ($15.77). 207,726 shares were traded during mid-day trading, an increase of 204% from the average session volume of 68,245 shares. The stock had previously closed at €14.05 ($14.79).
CompuGroup Medical SE & Co. KGaA Stock Up 8.2 %
The company has a current ratio of 0.98, a quick ratio of 0.97 and a debt-to-equity ratio of 132.82. The company has a 50-day simple moving average of €13.96 and a 200 day simple moving average of €18.33. The company has a market cap of $786.30 million, a P/E ratio of 24.52, a P/E/G ratio of 1.64 and a beta of 0.88.
About CompuGroup Medical SE & Co. KGaA
(
Get Free Report)
CompuGroup Medical SE & Co KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions.
Read More
Before you consider CompuGroup Medical SE & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompuGroup Medical SE & Co. KGaA wasn't on the list.
While CompuGroup Medical SE & Co. KGaA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
